Literature DB >> 11140380

An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis.

C Levin1, H I Maibach.   

Abstract

We review controlled trials of corticosteroid effect in experimentally elicited acute nickel contact dermatitis in man, in the hope of clarifying optimal efficacy for clinical use. To maximize discrimination and objectivity, we focus on data with 1 well-characterized allergen, nickel, in studies utilizing bioengineering documentation. Higher potency corticosteroids are effective (unlike in experimental irritant contact dermatitis), but optimum schedules still require definition.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11140380     DOI： 10.1034/j.1600-0536.2000.043006317.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN： 0105-1873            Impact factor:   6.600


  3 in total

1.  Dermacase. Allergic contact dermatitis.

Authors:  Sunil Kalia; Stewart P Adams
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275

Review 2.  Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications.

Authors:  Elaine C Siegfried; Adelaide A Hebert
Journal:  J Clin Med       Date:  2015-05-06       Impact factor: 4.241

Review 3.  Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG.

Authors:  Jochen Brasch; Detlef Becker; Werner Aberer; Andreas Bircher; Birger Kränke; Kirsten Jung; Bernhard Przybilla; Tilo Biedermann; Thomas Werfel; Swen Malte John; Peter Elsner; Thomas Diepgen; Axel Trautmann; Hans F Merk; Thomas Fuchs; Axel Schnuch
Journal:  Allergo J Int       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.